Methods | RCT 2-arm parallel group design. | |
Participants | Brazil: hospital. 56 women. No information in abstract about participant inclusion criteria or characteristics |
|
Interventions | Experimental: IM nalbuphine 10 mg. Control: IM pethidine 100 mg. |
|
Outcomes | Analgesia and side effects. Neonatal: Apgar score. |
|
Notes | Abstract only: insufficient information about participants. Not reported if > 1 dose given or anti-emetic. |
|
Risk of bias | ||
Bias | Authors’ judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | Described as “randomly selected” but not explained how. |
Allocation concealment (selection bias) | Unclear risk | Not mentioned. |
Blinding (performance bias and detection bias) Women |
Unclear risk | Not mentioned. |
Blinding (performance bias and detection bias) Clinical staff |
Unclear risk | Not mentioned. |
Blinding (performance bias and detection bias) Outcome assessor |
Unclear risk | Not mentioned. |
Incomplete outcome data (attrition bias) All outcomes |
Unclear risk | Not mentioned. |
Selective reporting (reporting bias) | Unclear risk | Impossible to decipher. |
Other bias | Unclear risk | Impossible to decipher. |